Twist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($1.47), $0.71 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $81.5 million versus the consensus estimate of $77.4 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2024 revenue of $310-311 million, versus the consensus of $303.8 million.

Twist Bioscience Corporation sees Q4 2024 revenue of $82-83 million, versus the consensus of $79.92 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.